loading
전일 마감가:
$0.83
열려 있는:
$0.8384
하루 거래량:
58,971
Relative Volume:
0.02
시가총액:
$8.93M
수익:
$1.52M
순이익/손실:
$-13.97M
주가수익비율:
-0.2785
EPS:
-3.05
순현금흐름:
$-13.29M
1주 성능:
-3.47%
1개월 성능:
-3.48%
6개월 성능:
+3.60%
1년 성능:
-17.52%
1일 변동 폭
Value
$0.815
$0.87
1주일 범위
Value
$0.81
$0.91
52주 변동 폭
Value
$0.55
$3.06

Predictive Oncology Inc Stock (POAI) Company Profile

Name
명칭
Predictive Oncology Inc
Name
전화
412-432-1500
Name
주소
91 43RD STREET, PITTSBURGH, MN
Name
직원
24
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
POAI's Discussions on Twitter

POAI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Instruments & Supplies icon
POAI
Predictive Oncology Inc
0.8495 8.93M 1.52M -13.97M -13.29M -3.05
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
538.18 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
177.62 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
89.09 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
256.31 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
222.45 16.36B 2.90B 467.20M 306.90M 6.37

Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-19 개시 H.C. Wainwright Buy

Predictive Oncology Inc 주식(POAI)의 최신 뉴스

pulisher
Jun 18, 2025

Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Up 50.6% in May - Defense World

Jun 18, 2025
pulisher
Jun 12, 2025

Labcorp (LH) Gains Exclusive 3D Liver Models from Predictive Onc - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology develops liver toxicity models for Labcor By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Inc. Develops Functional 3D Organoid Models Exclusively for Labcorp - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology develops liver toxicity models for Labcor - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - The Manila Times

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Revolutionary 3D Organoid Models: How Predictive Oncology's Exclusive Labcorp Deal Transforms Drug Testing - Stock Titan

Jun 12, 2025
pulisher
Jun 11, 2025

Predictive Oncology Faces Nasdaq Delisting Notice - TipRanks

Jun 11, 2025
pulisher
Jun 07, 2025

Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Major AI Breakthrough in Cancer Research: Leading Pharma Companies Unite in Revolutionary Oncology Initiative - Stock Titan

Jun 05, 2025
pulisher
Jun 02, 2025

SEC Form 424B5 filed by Predictive Oncology Inc. - Quantisnow

Jun 02, 2025
pulisher
Jun 01, 2025

'It's not something you choose to do, it's something you have to do': CEO & artist shares story - WTAE

Jun 01, 2025
pulisher
May 30, 2025

Predictive Oncology (NASDAQ:POAI) Stock Crosses Below 200 Day Moving Average – Time to Sell? - Defense World

May 30, 2025
pulisher
May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology says court denies Renovaro motion for expedited trial - TipRanks

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology (POAI) Addresses Legal Dispute with Renovaro - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July | POAI Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Delaware Court Rejects Renovaro's Rush to Trial Against Predictive Oncology, Cites Critical Delays - Stock Titan

May 27, 2025
pulisher
May 23, 2025

Renovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology Merger - MSN

May 23, 2025
pulisher
May 22, 2025

Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish By Stocktwits - Investing.com India

May 22, 2025
pulisher
May 22, 2025

UPDATERenovaro Inc. Announces Expedited Trial for 2025 Lawsui - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology (POAI) Advances AI-Driven Cancer Drug Discov - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Sues Predictive Oncology (POAI) Over Merger Agreement D - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Gets Expedited Trial in Predictive Oncology Merger Dispute - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Renovaro Sues Predictive Oncology (POAI) Over Merger Agreement Dispute | POAI Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology | RENB Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Secures Ruling to Expedite Trial Against Predictive Oncology Over Breach of Merger Agreement - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Court Fast-Tracks Renovaro's Lawsuit to Force Predictive Oncology Merger After 50% Stock Jump Drama - Stock Titan

May 22, 2025
pulisher
May 22, 2025

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition | POAI Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology harnesses AI for drug discovery - Investing.com

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology moves to leverage biobank using AI - TipRanks

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology harnesses AI for drug discovery By Investing.com - Investing.com Nigeria

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology Inc. Advances AI-Driven Drug Discovery with Extensive Biobank of Tumor Samples - Nasdaq

May 22, 2025
pulisher
May 22, 2025

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Major AI Breakthrough: How 150,000 Live Tumor Samples Are Revolutionizing Cancer Drug Discovery - Stock Titan

May 22, 2025
pulisher
May 20, 2025

Predictive Oncology issued shareholder letter - TipRanks

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology (POAI) Showcases Recent Achievements and Future Plans | POAI Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Expands AI-Driven Platform to Include Biomarker Discovery and Drug Repurposing for Precision Oncology - Nasdaq

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: ... - Bluefield Daily Telegraph

May 20, 2025

Predictive Oncology Inc (POAI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.90
price up icon 2.70%
$193.56
price up icon 2.14%
medical_instruments_supplies COO
$72.97
price up icon 2.56%
$65.51
price up icon 0.47%
medical_instruments_supplies BAX
$31.18
price up icon 3.02%
medical_instruments_supplies WST
$222.50
price up icon 1.64%
자본화:     |  볼륨(24시간):